Sign in
CompletedNo phase

Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis

Key facts

Who runs it
Atlas University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
40 people enrolled
Started
5 Sept 2023
Ended
1 Jan 2024
Type of study
Observational, 2 groups
Treatments tested
  • Demographic Data
  • Disease History
  • Pulmonary Function Test
  • Reaction Time
  • Functional Capacity
  • Dyspnea Perception
  • Quality of Life
  • Fear of movement
  • Ability of Motor Imagery
  • Cognitive Functions
Record updated
8 October 2024

Who can take part

Age
7 years to 18 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Diagnosed with cystic or non-cystic bronchiectasis
  • Being clinically stable
  • Not having an exacerbation or infection
  • Being between the ages of 7-18
  • To be able to read and understand Turkish

Who cannot take part

  • Unstable concomitant cardiac, orthopedic or neurologic disease
  • History of previous lung or liver transplantation
  • History of acute exacerbation and/or hospitalization in the last 1 month
  • Changes in medical treatment during the study period

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers.

The 2 groups in the trial

  • Children with Bronchiectasis Experiment Group

    Children with bronchiectasis Participants will be required to sign an informed consent form before the evaluation. Assesment Methods: 1. Demographic data will be collected verbally. 2. The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned. 3. Pulmonary Function Test will be applied. 4. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test. 5. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test. 6. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea. 7. Quality of life will be assessed with the "Quality of Life Scale for Children". 8. Fear of movement will be assessed with the Tampa Kinesiophobia Scale. 9. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery. 10. Cognitive functions will be assessed with Trail Making Test and Stroop Test.

    Treatment: Demographic Data, Disease History, Pulmonary Function Test, Reaction Time, Functional Capacity, Dyspnea Perception, Quality of Life, Fear of movement, Ability of Motor Imagery, and Cognitive Functions

  • Healthy Controls

    Healthy Peers Participants will be required to sign an informed consent form before the evaluation. Assessment Methods: 1. Demographic data (age, height, weight, BMI) will be collected verbally via the assessment form. 2. Pulmonary Function Test will be applied. 3. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test. 4. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test. 5. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea. 6. Quality of life will be assessed with the "Quality of Life Scale for Children". 7. Fear of movement will be assessed with the Tampa Kinesiophobia Scale. 8. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery. 9. Cognitive functions will be assessed with Trail Making Test and Stroop Test.

    Treatment: Demographic Data, Pulmonary Function Test, Reaction Time, Functional Capacity, Dyspnea Perception, Quality of Life, Fear of movement, Ability of Motor Imagery, and Cognitive Functions

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
8 October 2024